Skip to main content
Caplight Logo









Oral Biolife Inc.

Oral Biolife Inc.

Private
Bethlehem, PennsylvaniaHealthcare & Life Scienceshttps://oralbiolife.com/

Last Round

Series A

Mar 6, 2026

Total Funding Raised

$200,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oral Biolife Inc. is a biotechnology company that develops dental therapeutics, including its lead asset Ambrilux Dental Gel, designed for the treatment of periodontal disease through bone regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyregenerative medicinemedical deviceperiodontal disease treatmentbone regenerationpiezoelectric therapybiomaterialsveterinary medicinehydrogel scaffoldosteogenesistissue engineeringbioactive materialsdental technologybiotech startupmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oral Biolife Inc. Comparables

Compare Oral Biolife Inc. with similar companies based on industry and business-model similarity.

Oral Biolife Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioChange
80%
HysensBio
76%
Geistlich Pharma
69%

Oral Biolife Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 6, 2026
SeedOct 15, 2025
VC RoundJun 24, 2025
GrantJan 25, 2021

Key People

Founding team and executive leadership

Greg Ambra

Chief Executive Officer

Executive Team

Oral Biolife Inc. Investors

Notable investors and investment history

Oral Biolife Inc. investors
InvestorRounds
Benjamin Franklin Technology PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2026

    $10M round completed.

  • May 2, 2025

    Monthly visitors grew 36% MoM, reaching 1.5K.

Recent news

Latest coverage and updates

  • hiresJul 9, 2026

    Oral Biolife Inc. hired Thomas J. Corrigan as Vice President of Finance on Jul 9th '26.

Oral Biolife Inc. Filings

Explore SEC and related filing metadata, where available.

Oral Biolife Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oral Biolife Inc.'s valuation, stock price, and market status.

Is Oral Biolife Inc. a public or private company?

Oral Biolife Inc. is a private company.

What is the current stock price of Oral Biolife Inc.?

Oral Biolife Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Oral Biolife Inc. worth (valuation)?

Valuation information for Oral Biolife Inc. is not publicly available.

Can I buy Oral Biolife Inc. stock?

Oral Biolife Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oral Biolife Inc.'s last funding round?

Oral Biolife Inc.'s most recent funding round was Seed on June 24, 2025.

Who are the main investors in Oral Biolife Inc.?

Key investors in Oral Biolife Inc. include Benjamin Franklin Technology Partners.

Will Oral Biolife Inc. IPO soon?

No public IPO plans have been announced for Oral Biolife Inc..

How can I track Oral Biolife Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oral Biolife Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBethlehem, Pennsylvania
Employee Range9
Year Founded2022
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?